Cargando…

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease

Few studies have investigated the effects of various antidiabetic agents on individuals with both type 2 diabetes mellitus (T2DM) and Chronic obstructive pulmonary disease (COPD). This study compared mortality, cardiovascular events and respiratory outcomes in individuals with both T2DM and COPD tak...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Fu-Shun, Wei, James Cheng-Chung, Yang, Yu-Cih, Hsu, Chih-Cheng, Hwu, Chii-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695877/ https://www.ncbi.nlm.nih.gov/pubmed/34957135 http://dx.doi.org/10.3389/fmed.2021.729518

Ejemplares similares

Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design
por: Yen, Fu-Shun, et al.
Publicado: (2018)

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Parental Income Level and Risk of Developing Type 2 Diabetes in Youth
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Diabetes, hypertension, and cardiovascular disease development
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2019)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes
por: Yeh, Yun Kai, et al.
Publicado: (2023)

Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?
por: Yen, Fu‐Shun, et al.
Publicado: (2023)

Acupuncture Point Stimulation Treatments Combined With Conventional Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis
por: Tsai, Cheng-Lin, et al.
Publicado: (2021)

Effect of smoking on the development of chronic obstructive pulmonary disease in young individuals: a nationwide cohort study
por: Chung, Chiwook, et al.
Publicado: (2023)

The Impact of Alcohol Consumption on Cognitive Impairment in Patients With Diabetes, Hypertension, or Chronic Kidney Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Corrigendum: The impact of alcohol consumption on cognitive impairment in patients with diabetes, hypertension, or chronic kidney disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease
por: Li, Xiao-Fang, et al.
Publicado: (2022)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hi7k1fn33em7s6ttd8l58sfh58